URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1
|
disease |
|
Finding
|
1
|
2
|
0.600 |
limited |
1.000 |
1 |
2
|
2016 |
2016 |
Hyperuricemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
7
|
25
|
0.500 |
None |
1.000 |
1 |
2
|
2011 |
2019 |
CUI: |
C0018099 |
Disease: |
Gout
|
Gout
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
9
|
2348
|
0.450 |
None |
1.000 |
2 |
52
|
2008 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
702
|
856
|
0.400 |
None |
0.958 |
2 |
|
2004 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
538
|
763
|
0.400 |
None |
0.962 |
1 |
|
1999 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
316
|
0.400 |
None |
1.000 |
1 |
|
2000 |
2017 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1074
|
1390
|
0.400 |
None |
0.960 |
1 |
|
2000 |
2019 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
55
|
19
|
0.340 |
None |
1.000 |
1 |
|
2007 |
2011 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
277
|
586
|
0.330 |
None |
1.000 |
2 |
|
2008 |
2016 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
52
|
182
|
0.320 |
None |
1.000 |
1 |
|
2014 |
2016 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
53
|
3
|
0.310 |
None |
1.000 |
1 |
|
2009 |
2009 |
Secondary Biliary Cholangitis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenoma, Trabecular
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
525
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Biliary Cirrhosis, Primary, 1
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Papillary adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adenoma, Monomorphic
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
174
|
1789
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
47
|
609
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
42
|
36
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
155
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
53
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |